Kenfarb & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Kenfarb & Co's AMGN Position: Q3 2023 in Review
Kenfarb & Co reduced its Amgen (AMGN) stake by 1.1% in Q3 2023, selling an estimated $12.5K and leaving 4,685 shares worth $1.26M. The position accounts for 1.15% of the portfolio, ranked #27.
Kenfarb & Co first reported a position in AMGN in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.36M in Q4 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Kenfarb & Co held 4,685 shares of Amgen worth $1.26M as of Q3 2023.
- Kenfarb & Co sold 50 Amgen shares in Q3 2023, an estimated $12.5K.
- Amgen made up 1.15% of Kenfarb & Co's portfolio in Q3 2023, its #27 holding.
- Kenfarb & Co first reported a position in Amgen in Q4 2021 and has held it in 8 quarters since.
- Kenfarb & Co's Amgen position peaked at $1.36M in Q4 2022.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.